Oncternal Therapeutics (ONCT) Stock Forecast & Price Target

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

$9.15

+0.55 (+6.40%)

(As of 04/19/2024 ET)

Oncternal Therapeutics Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 3 Analyst Ratings

Analysts' Consensus Price Target

$31.33
242.44% Upside

High Forecast	$40.00
Average Forecast	$31.33
Low Forecast	$26.00

Type	Current Forecast 4/20/23 to 4/19/24	1 Month Ago 3/21/23 to 3/20/24	3 Months Ago 1/20/23 to 1/20/24	1 Year Ago 4/20/22 to 4/20/23
Consensus Rating	Moderate Buy	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	0 Buy rating(s)
Hold	1 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$31.33	$69.00	$71.50	$115.33
Predicted Upside	242.44% Upside	765.99% Upside	715.49% Upside	701.26% Upside

Get Oncternal Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ONCT and its competitors with MarketBeat's FREE daily newsletter.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

ONCT Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ONCT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oncternal Therapeutics Stock vs. The Competition

Type	Oncternal Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.68	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	256.87% Upside	967.12% Upside	11.77% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/15/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$30.00 ➝ $28.00	+197.87%
12/4/2023	Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Dolliver Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$40.00	+497.19%
9/7/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Watsek Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$26.00	+343.84%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:51 PM ET.

ONCT Price Target - Frequently Asked Questions

What is Oncternal Therapeutics's consensus rating and price target?: According to the issued ratings of 3 analysts in the last year, the consensus rating for Oncternal Therapeutics stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for ONCT. The average twelve-month price prediction for Oncternal Therapeutics is $31.33 with a high price target of $40.00 and a low price target of $26.00. Learn more on ONCT's analyst rating history.
Do Wall Street analysts like Oncternal Therapeutics more than its competitors?: Analysts like Oncternal Therapeutics less than other Medical companies. The consensus rating score for Oncternal Therapeutics is 2.67 while the average consensus rating score for medical companies is 2.68. Learn more on how ONCT compares to other companies.
Does Oncternal Therapeutics's stock price have much upside?: According to analysts, Oncternal Therapeutics's stock has a predicted upside of 328.13% based on their 12-month stock forecasts.

What analysts cover Oncternal Therapeutics?: Oncternal Therapeutics has been rated by HC Wainwright in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:ONCT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oncternal Therapeutics (ONCT) Stock Forecast & Price Target

Oncternal Therapeutics Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

ONCT Analyst Ratings By Month

ONCT Price Targets by Month

Oncternal Therapeutics Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

ONCT Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info